LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 31.55 | 771.67 | 1135 | 3196 | 0.3551 | 0.2070 | MN20160304_L01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 31.55 | 771.67 | 1205 | 3196 | 0.3770 | 0.2428 | MN20160304_L01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 33.78 | 771.67 | 1128 | 3499 | 0.3223 | 0.1901 | MN20160304_L01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 33.78 | 771.67 | 1206 | 3499 | 0.3446 | 0.2272 | MN20160304_L01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 36.00 | 771.67 | 1126 | 3884 | 0.2899 | 0.1759 | MN20160304_L01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 36.00 | 771.67 | 1183 | 3884 | 0.3045 | 0.2011 | MN20160304_L01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 38.22 | 771.67 | 1119 | 4299 | 0.2603 | 0.1618 | MN20160304_L01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 38.22 | 771.67 | 1201 | 4299 | 0.2793 | 0.1954 | MN20160304_L01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 40.44 | 771.67 | 1105 | 4738 | 0.2332 | 0.1470 | MN20160304_L01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 40.44 | 771.67 | 1201 | 4738 | 0.2535 | 0.1841 | MN20160304_L01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 42.67 | 771.67 | 1092 | 5155 | 0.2118 | 0.1351 | MN20160304_L01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 42.67 | 771.67 | 1223 | 5155 | 0.2372 | 0.1830 | MN20160304_L01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 44.89 | 771.67 | 1082 | 5541 | 0.1953 | 0.1262 | MN20160304_L01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 44.89 | 771.67 | 1207 | 5541 | 0.2178 | 0.1703 | MN20160304_L01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 47.11 | 771.67 | 1083 | 5941 | 0.1823 | 0.1220 | MN20160304_L01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 47.11 | 771.67 | 1194 | 5941 | 0.2010 | 0.1598 | MN20160304_L01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 49.33 | 771.67 | 1064 | 6392 | 0.1664 | 0.1111 | MN20160304_L01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 49.33 | 771.67 | 1196 | 6392 | 0.1871 | 0.1545 | MN20160304_L01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 51.55 | 771.67 | 1055 | 6829 | 0.1545 | 0.1045 | MN20160304_L01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 51.55 | 771.67 | 1182 | 6829 | 0.1731 | 0.1452 | MN20160304_L01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 53.77 | 771.67 | 1037 | 7256 | 0.1429 | 0.0957 | MN20160304_L01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 53.77 | 771.67 | 1187 | 7256 | 0.1636 | 0.1425 | MN20160304_L01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 55.99 | 771.67 | 1013 | 7690 | 0.1317 | 0.0855 | MN20160304_L01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 55.99 | 771.67 | 1143 | 7690 | 0.1486 | 0.1257 | MN20160304_L01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 58.21 | 771.67 | 1015 | 8085 | 0.1255 | 0.0842 | MN20160304_L01 | E13 |